Litcius/Paper detail

Takotsubo Cardiomyopathy After mRNA COVID-19 Vaccination

Martina Boscolo Berto, Giancarlo Spano, Benedikt Wagner, Benedikt Bernhard, Jonas Häner, A Huber, Christoph Gräni

2021Heart Lung and Circulation27 citationsDOIOpen Access PDF

Abstract

A healthy 63-year-old woman with no cardiovascular risk factors was admitted to the emergency room with new-onset dyspnoea and fever. The symptoms started 1 day after receiving the first of two mRNA-1273 (Moderna, Cambridge, MA, USA) COVID-19 vaccinations. She had no other prior complaints. A retronasal severe acute respiratory syndrome coronavirus 2 polymerase chain reaction test was negative. Laboratory tests revealed normal results for creatinine, creatine kinase, and creatine kinase MB (myocardial type). High-sensitivity troponin T was elevated at 320 ng/L (normal: <14 ng/L), and N-terminal pro-B-type natriuretic peptide was highly elevated at 10,180 pg/mL (normal: <284 pg/mL). C-reactive protein was elevated, but the leucocytes were within the normal range at 8.44 g/L (reference interval [RI]: 3.00–10.5 g/L). Urine and blood cultures were negative. Computed tomography scan of the chest revealed no pulmonary embolism but did show signs of heart failure. An electrocardiogram showed negative T waves over the inferior/anterior leads. Invasive coronary angiography ruled out coronary artery disease, but the ventriculogram (Figure 1) showed mid-ventricular to apical ballooning (asterisk) with preserved basal contraction (blues arrows) and a moderately impaired left ventricular ejection fraction of 40%. Apical ballooning was confirmed by echocardiography and cardiac magnetic resonance imaging (CMR). CMR tissue characterisation further depicted extensive oedema in the mid-ventricular/apical segments (i.e., T2-weighted imaging in the myocardium vs skeletal muscle with a signal intensity ratio of >2.0), elevated T2 mapping at 56 ms (RI: 42–50 ms), elevated T1 mapping at 1,158 ms (RI: 903–1,059 ms), and the extracellular volume fraction was elevated at 35% (RI: 25±4%). There was no late gadolinium enhancement suggesting peri-/myocarditis and no pleural or pericardial effusion. As there were no other stressors that could be determined to be underlying the midventricular/apical oedema and ballooning, the most probable diagnosis of COVID-19 vaccine-induced Takotsubo cardiomyopathy (TCM) was made. Although myocarditis is a possible differential diagnosis after COVID-19 vaccination [[1]Abu Mouch S. Roguin A. Hellou E. Ishai A. Shoshan U. Mahamid L. et al.Myocarditis following COVID-19 mRNA vaccination.Vaccine. 2021; 39: 3790-3793Crossref PubMed Scopus (164) Google Scholar], the clinical and investigative features of this case were strongly suggestive of TCM. There have been rare reports of TCM after influenza vaccination [[2]Singh K. Marinelli T. Horowitz J.D. Takotsubo cardiomyopathy after anti-influenza vaccination: catecholaminergic effects of immune system.Am J Emerg Med. 2013; 31: 1627Abstract Full Text Full Text PDF PubMed Scopus (17) Google Scholar,[3]Santoro F. Ieva R. Ferraretti A. Carpagnano G. Pappalardo I. De Gennaro L. et al.Tako-Tsubo cardiomyopathy after influenza vaccination.Int J Cardiol. 2013; 167: e51-e52Abstract Full Text Full Text PDF PubMed Scopus (8) Google Scholar], with an underlying pathophysiology of systemic inflammatory stress reaction after vaccination with a sympathovagal imbalance towards adrenergic predominance [[4]Lanza G.A. Barone L. Scalone G. Pitocco D. Sgueglia G.A. Mollo R. et al.Inflammation-related effects of adjuvant influenza A vaccination on platelet activation and cardiac autonomic function.J Intern Med. 2011; 269: 118-125Crossref PubMed Scopus (31) Google Scholar]. TCM confirmed by CMR after a COVID-19 vaccination has not yet been reported and may be considered as a differential diagnosis besides myocarditis in this clinical setting. Letter to the Editor Regarding: What Triggers Takotsubo After a SARS-CoV-2 Vaccination? Heart Lung Circ. 2021;30(12):e119–20Heart, Lung and CirculationVol. 31Issue 5PreviewWe read with interest the case report by Boscolo Berto et al. about a 63-year-old female who developed the classical type of Takotsubo cardiomyopathy (TTS) one day after her first jab of the Moderna vaccine [1]. The patient completely recovered without any treatment [1]. The study is appealing but raises several comments and concerns. Full-Text PDF

Topics & Concepts

MedicineInternal medicineCardiologyEjection fractionCreatine kinaseMyocarditisTroponinTroponin TAcute coronary syndromeCoronary artery diseaseCardiac magnetic resonance imagingHeart failureNatriuretic peptideCardiomyopathyPulmonary embolismMagnetic resonance imagingMyocardial infarctionRadiologyTakotsubo Cardiomyopathy and Associated PhenomenaCardiac electrophysiology and arrhythmiasPeripheral Neuropathies and Disorders
Takotsubo Cardiomyopathy After mRNA COVID-19 Vaccination | Litcius